Journal: Science Advances
Article Title: Stat5 induces androgen receptor ( AR ) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling
doi: 10.1126/sciadv.adi2742
Figure Lengend Snippet: ( A ) CWR22Pc and LAPC4 cells were treated with vehicle (DMSO), ADT (withdrawal of androgens), or ENZ (20 μM) for 3 days followed by continuation with DMSO, ADT, ENZ (20 μM), or IST5-002 (800 nM) for 8 days. The fractions of surviving attached cells were determined by crystal violet staining and counting. ( B ) AR-FL, AR-V7, and AR-V9 mRNA levels of cells in parallel wells were evaluated by qRT-PCR. ( C ) Experimental design for the sequential therapy of the xenograft tumors in vivo. A two-phase in vivo experiment using vehicle or ENZ as first-line therapy (phase 1, 13 days) and vehicle, ENZ, or IST5-002 as second-line therapy (phase 2, 18 days). On day 31, mice were euthanized and CWR22Pc xenograft tumors were collected for analyses. ( D ) AR-FL, AR-V7, and AR-V9 mRNA levels were determined in the endpoint tumors by qRT-PCR. Hypothesis tests were performed using ANOVA with post hoc testing using the Student’s t test with Bonferroni multiplicity corrections. Significance levels are indicated for relevant hypotheses as * P < 0.05, ** P < 0.01, and *** P < 0.001.
Article Snippet: ENZ was dissolved in 0.5% Tween 80 (Sigma-Aldrich)/phosphate-buffered saline (PBS), and IST5-002 in 0.3% hydroxypropyl cellulose (Sigma-Aldrich)/H 2 O.
Techniques: Staining, Quantitative RT-PCR, In Vivo